Form 4 for TWST Twist Bioscience Corp
Accepted 2021-07-27 00:00:00 ET · period of report 2021-07-23 · accession 0001214659-21-007872 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-27 | 2021-07-23 | TWST | Leproust Emily M. | Pres, CEO, Dir | F - Tax | $117.34 | -944 | 254.4K | -0.4% | -$110.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-23 | F | D | 944 | $117.34 | 254,412 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). |